TriSalus Life Sciences (TLSI) Non-Current Assets (2020 - 2026)
TriSalus Life Sciences (TLSI) posted quarterly Non-Current Assets of $2.8 million for Q1 2026, down 19.5% year-over-year from $3.5 million in Q1 2025, and down 7.97% quarter-over-quarter from $3.1 million in Q4 2025.
TriSalus Life Sciences (TLSI) Non-Current Assets (2020 - 2026) Analysis & Trends
TriSalus Life Sciences' Non-Current Assets history runs 7 years deep, the most recent figure standing at $2.8 million for Q1 2026.
- In Q1 2026, Non-Current Assets fell 19.5% year-over-year to $2.8 million; the TTM figure through Mar 2026 stood at $12.3 million (down 17.97% YoY), while the FY2025 annual figure was $3.1 million, down 6.51% from the prior year.
- Non-Current Assets for Q1 2026 stood at $2.8 million, down from $3.1 million in the prior quarter.
- The five-year high for Non-Current Assets was $251.0 million in Q3 2022, with the low at $2.8 million in Q1 2026.
- The 5-year median for Non-Current Assets is $4.5 million (2024), against an average of $48.7 million.
- The sharpest annual moves came in 2022 and 2023: Non-Current Assets climbed 0.38% in 2022, then tumbled 98.2% in 2023.
- TriSalus Life Sciences' Non-Current Assets stood at $4.8 million in 2022, then fell by 21.86% to $3.7 million in 2023, then decreased by 11.62% to $3.3 million in 2024, then fell by 6.51% to $3.1 million in 2025, then retreated by 7.97% to $2.8 million in 2026.
- Business Quant data shows TLSI's Non-Current Assets at $2.8 million in Q1 2026, $3.1 million in Q4 2025, and $3.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 33.51 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 37.24 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 7.05 Bn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 2.37 Bn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 26.75 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 20.19 Bn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 8.29 Bn |
| 10 | TriSalus Life Sciences | 306.64 Mn | 260.35 Mn | 9.90 Mn | 2.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.70 Mn |
| Mar 31, 2026 | 2.84 Mn |
| Dec 31, 2025 | 3.09 Mn |
| Sep 30, 2025 | 3.14 Mn |
| Jun 30, 2025 | 3.23 Mn |
| Mar 31, 2025 | 3.53 Mn |
| Dec 31, 2024 | 3.30 Mn |
| Sep 30, 2024 | 3.67 Mn |
| Jun 30, 2024 | 4.49 Mn |
| Mar 31, 2024 | 4.70 Mn |
| Dec 31, 2023 | 3.74 Mn |
| Sep 30, 2023 | 4.51 Mn |
| Jun 30, 2023 | 12.08 Mn |
| Mar 31, 2023 | 20.22 Mn |
| Dec 31, 2022 | 4.78 Mn |
| Sep 30, 2022 | 251.02 Mn |
| Jun 30, 2022 | 250.29 Mn |
| Mar 31, 2022 | 250.05 Mn |
| Dec 31, 2021 | 250.01 Mn |
| Sep 30, 2021 | 250.06 Mn |